中国当代医药
中國噹代醫藥
중국당대의약
China Modern Medicine
2015年
30期
80-82
,共3页
奥氮平%齐拉西酮%早期精神分裂症%不良反应
奧氮平%齊拉西酮%早期精神分裂癥%不良反應
오담평%제랍서동%조기정신분렬증%불량반응
Olanzapine%Ziprasidone%Early schizophrenia%Adverse reaction
目的:探讨齐拉西酮与奥氮平治疗早期精神分裂症患者的临床价值,分析其对血脂代谢、血糖等指标的影响。方法随机将我院2012年7月~2014年5月收治的89例早期精神分裂症患者分为研究组(46例)与对照组(43例),对照组应用奥氮平治疗,研究组应用齐拉西酮治疗,观察两组患者的治疗有效率、阳性与阴性症状量表(PANSS)评分、不良反应、血糖、血脂及体质量指数(BMI)等指标。结果两组总治疗有效率比较,差异无统计学意义(P>0.05);研究组血糖、血脂、BMI、PANSS评分及不良反应发生率等指标均优于对照组(P<0.05)。结论齐拉西酮与奥氮平治疗早期精神分裂症患者,能取得相当疗效,具有起效快、不良反应少的特点,值得临床广泛推广。
目的:探討齊拉西酮與奧氮平治療早期精神分裂癥患者的臨床價值,分析其對血脂代謝、血糖等指標的影響。方法隨機將我院2012年7月~2014年5月收治的89例早期精神分裂癥患者分為研究組(46例)與對照組(43例),對照組應用奧氮平治療,研究組應用齊拉西酮治療,觀察兩組患者的治療有效率、暘性與陰性癥狀量錶(PANSS)評分、不良反應、血糖、血脂及體質量指數(BMI)等指標。結果兩組總治療有效率比較,差異無統計學意義(P>0.05);研究組血糖、血脂、BMI、PANSS評分及不良反應髮生率等指標均優于對照組(P<0.05)。結論齊拉西酮與奧氮平治療早期精神分裂癥患者,能取得相噹療效,具有起效快、不良反應少的特點,值得臨床廣汎推廣。
목적:탐토제랍서동여오담평치료조기정신분렬증환자적림상개치,분석기대혈지대사、혈당등지표적영향。방법수궤장아원2012년7월~2014년5월수치적89례조기정신분렬증환자분위연구조(46례)여대조조(43례),대조조응용오담평치료,연구조응용제랍서동치료,관찰량조환자적치료유효솔、양성여음성증상량표(PANSS)평분、불량반응、혈당、혈지급체질량지수(BMI)등지표。결과량조총치료유효솔비교,차이무통계학의의(P>0.05);연구조혈당、혈지、BMI、PANSS평분급불량반응발생솔등지표균우우대조조(P<0.05)。결론제랍서동여오담평치료조기정신분렬증환자,능취득상당료효,구유기효쾌、불량반응소적특점,치득림상엄범추엄。
Objective To explore the clinical value of ziprasidone and olanzapine in the treatment of early schizophre-nia and analyze the effects on blood lipid metabolism and blood glucose. Methods 89 patients with early schizophrenia treated in our hospital from July 2012 to May 2014 were selected and randomly divided into the study group (46 cases) and control group (43 cases).Patients in control group were treated by olanzapine while patients in study group were treated by ziprasidone.After treatment,the effective rates,PANSS scores,adverse effects,blood glucose,blood lipid and BMI between two groups were observed. Results The overall effective rates between two groups was comparable re-spectively,with no statistical differenc (P>0.05);blood glucose,blood lipid,BMI,PANSS score and AE rate in study group was superior to that of control group respectively (P<0.05). Conclusion The curative effects of ziprasidone and olanzap-ine in the treatment of early schizophrenia is comparable,and ziprasidone has rapid effect and less adverse reaction, which is worthy to be promoted in clinic.